← Leaderboards
Katherine Chanel Konvinse
Vanderbilt University
$100,858
Attributed
$100,858
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $42.9K · FY2017–19$50K$37.5K$25K$12.5K$0
'17
'18
'19
Funding mix
By agency
NIH$100,858 · 1
By mechanism
F30$100,858 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Joshua C. Denny$39,465,922
- Grover P Miller$2,356,837
- Mia A. Levy$4,206,959
- Marylyn D Ritchie$17,567,522
- Diane S Kenney$504,172
Others in their field
Other Emerging Leaders on “Acute”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$51,003,204
- Julie Ake · National Institute Of Allergy And Infectious Diseases$41,692,120
- Xinhua Li · Nano Terra, Inc.$29,991,620
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$29,269,420
- Evan Z Macosko · Broad Institute, Inc.$27,107,011
Research focus
AcuteCutaneousAfricaAge RelatedAllelesAntigensAsiaAssociated SymptomBaseBiobankBiopsyBlocking AntibodiesBullaCarbamazepineCd8-Positive T-LymphocytesCellsCell SeparationCell SurfaceCharacteristicsClinical PhenotypeCollaborationsCross ReactivityCryopreserved CellCytokine
Grant awards (3)
Immunopathogenesis of nevirapine-induced severe T-cell-mediated adverse drug reactions$42,948
F30 · FY2019 · AI · contact PI
Immunopathogenesis of nevirapine-induced severe T-cell-mediated adverse drug reactions$29,195
F30 · FY2018 · AI · contact PI
Immunopathogenesis of nevirapine-induced severe T-cell-mediated adverse drug reactions$28,715
F30 · FY2017 · AI · contact PI